Alpha 2.0
Login Register
» Articles » PMID: 38603460

Emerging Synthetic Drugs for the Treatment of Hepatic Cirrhosis: a 2024 Update

Overview
Journal Expert Opin Emerg Drugs
Date 2024 Apr 11
PMID 38603460
Authors
Jonathan A Fallowfield
Maria Jimenez Ramos
Affiliations
Soon will be listed here.
Citing Articles

Innovative Drugs First Implemented in Type 2 Diabetes Mellitus and Obesity and Their Effects on Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Related Fibrosis and Cirrhosis.

Cazac-Panaite G, Lacatusu C, Grigorescu E, Fosalau A, Onofriescu A, Mihai B J Clin Med. 2025; 14(4).

PMID: 40004572 PMC: 11857078. DOI: 10.3390/jcm14041042.